ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
source: pixabay.com

ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy

  The patient, age 82, had recovered from a stroke several months ago. According to a recent article reported on dnyuz.com and originally published in the New York Times, the…

Continue Reading ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
ICYMI: Case Study Demonstrates Lambert-Eaton Myasthenic Syndrome May be Linked to Merkel Cell Carcinoma
source: pixabay.com

ICYMI: Case Study Demonstrates Lambert-Eaton Myasthenic Syndrome May be Linked to Merkel Cell Carcinoma

A recent study has found that Lambert-Eaton Myasthenic Syndrome (LEMS), a rare disease, could also be linked to another rare condition- Merkel cell carcinoma (MCC) which is a type of…

Continue Reading ICYMI: Case Study Demonstrates Lambert-Eaton Myasthenic Syndrome May be Linked to Merkel Cell Carcinoma

Community is Essential for Lambert-Eaton Myasthenia Syndrome Patients During the Pandemic

Quarantine during COVID-19 has been difficult for everyone. It's socially isolating, mentally draining, and physically limiting. We all find community different places. But no matter where we find it, it…

Continue Reading Community is Essential for Lambert-Eaton Myasthenia Syndrome Patients During the Pandemic
New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
source: pixabay.com

New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients

  New information, speculation, statistics, and predictions about COVID-19 are hitting the internet every day. Yet neurologists are attempting to answer their patients’ questions without having sufficient data that would…

Continue Reading New International Working Group Answers COVID-19 Questions from Myasthenia Gravis Patients
Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients
source: pixabay.com

Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients

According to a study published in the scientific journal Neurology, the survival rates of patients with Lambert-Eaton myasthenic syndrome (LEMS) were compared to that of the general population as well as…

Continue Reading Study Tracks Survival, Quality of Life, and Follow up for Lambert-Eaton Myasthenic Syndrome Patients

CMS is so Rare That it Took Four Years to Enroll Twenty People for a Trial

  According to a recent article in Biospace, Catalyst Pharmaceutical’s CMS-001 Phase 3 study ended with mixed results. The trial was billed as the first placebo-controlled double-blind study testing amifampridine phosphate (brand…

Continue Reading CMS is so Rare That it Took Four Years to Enroll Twenty People for a Trial
Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
geralt / Pixabay

Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US

According to a story from Lambert-Eaton News, a recent large scale study using data from the Veterans Affairs has determined that the prevalence of Lambert-Eaton myasthenic syndrome (LEMS) is similar…

Continue Reading Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US

Study Finds Firdapse is the Most Effective Treatment for LEMS, but it is Not The Most Commonly Prescribed

Results from the largest United States study to date of Lambert-Eaton myasthenic syndrome (LEMS) have indicated that for the majority of patients, Firdapse is the most effective treatment option currently…

Continue Reading Study Finds Firdapse is the Most Effective Treatment for LEMS, but it is Not The Most Commonly Prescribed

Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment

Lambert-Eaton Myasthenic Syndrome Lambert-Eaton Myasthenic syndrome (LEMs) is a rare autoimmune disease. The body's immune system targets nerve cells meaning patients experience muscle weakness. Other symptoms of LEMs include difficulty walking…

Continue Reading Bernie Sanders Fights Back Against 375,000 Price Tag for Lambert-Eaton Myasthenic Syndrome Treatment
A Recently Approved Drug for Lambert-Eaton Myasthenic Syndrome Could Cause Costs to Skyrocket
geralt / Pixabay

A Recently Approved Drug for Lambert-Eaton Myasthenic Syndrome Could Cause Costs to Skyrocket

According to a story from statnews.com, the recent FDA approval of a new treatment for Lambert-Eaton myasthenic syndrome could actually be bad news for patients. As it turns out, the…

Continue Reading A Recently Approved Drug for Lambert-Eaton Myasthenic Syndrome Could Cause Costs to Skyrocket
New Treatment for Lambert-Eaton Myasthenic Syndrome Approved by FDA!
https://patientworthy.com/wp-content/uploads/2018/11/perspective-175642_1280.png

New Treatment for Lambert-Eaton Myasthenic Syndrome Approved by FDA!

Lambert-Eaton Myasthenic Syndrome (LEMS) is an autoimmune disorder. It's a rare condition characterized by muscle weakness in the limbs. When the muscle weakness includes the respiratory muscles, the disease can…

Continue Reading New Treatment for Lambert-Eaton Myasthenic Syndrome Approved by FDA!